Pulse Biosciences, Inc operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone510-906-4600
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees54
Next Earnings Date10/29/2019 (Estimated)
OptionableOptionable
Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions
What is Pulse Biosciences' stock symbol?
Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."
How were Pulse Biosciences' earnings last quarter?
Pulse Biosciences Inc (NASDAQ:PLSE) posted its quarterly earnings data on Thursday, August, 8th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by $0.04. View Pulse Biosciences' Earnings History.
When is Pulse Biosciences' next earnings date?
What price target have analysts set for PLSE?
1 Wall Street analysts have issued 1-year price objectives for Pulse Biosciences' stock. Their forecasts range from $27.00 to $27.00. On average, they anticipate Pulse Biosciences' share price to reach $27.00 in the next twelve months. This suggests a possible upside of 92.9% from the stock's current price. View Analyst Price Targets for Pulse Biosciences.
What is the consensus analysts' recommendation for Pulse Biosciences?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Pulse Biosciences.
Has Pulse Biosciences been receiving favorable news coverage?
News coverage about PLSE stock has been trending neutral recently, InfoTrie reports. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pulse Biosciences earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Pulse Biosciences.
Who are some of Pulse Biosciences' key competitors?
Some companies that are related to Pulse Biosciences include AtriCure (ATRC), Orthofix Medical (OFIX), Silk Road Medical (SILK), Luminex (LMNX), Cryolife (CRY), Shockwave Medical (SWAV), Tactile Systems Technology (TCMD), Anika Therapeutics (ANIK), LeMaitre Vascular (LMAT), Cerus (CERS), SurModics (SRDX), Axonics Modulation Technologies (AXNX), Intersect ENT (XENT), AngioDynamics (ANGO) and Antares Pharma (ATRS).
What other stocks do shareholders of Pulse Biosciences own?
Who are Pulse Biosciences' key executives?
Pulse Biosciences' management team includes the folowing people:
- Mr. Darrin R. Uecker, Pres, CEO & Director (Age 53)
- Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 50)
- Mr. Edward A. Ebbers, Exec. VP & GM of Dermatology (Age 59)
- Dr. Richard Nuccitelli Ph.D., Chief Science Officer
- Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy
When did Pulse Biosciences IPO?
(PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.
How do I buy shares of Pulse Biosciences?
Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Pulse Biosciences' stock price today?
One share of PLSE stock can currently be purchased for approximately $14.00.
How big of a company is Pulse Biosciences?
Pulse Biosciences has a market capitalization of $290.78 million. The company earns $-37,540,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Pulse Biosciences employs 54 workers across the globe.View Additional Information About Pulse Biosciences.
What is Pulse Biosciences' official website?
How can I contact Pulse Biosciences?
Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]
MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
